Ultragenyx Pharmaceutical Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
EPS (Diluted)
$-6
Book Value Per Share
$-1
Free Cash Flow Per Share
$-5
Cash Per Share
$4
Revenue Per Share
$7
OCF Per Share
$-5
Return on Equity
-657.1%
Return on Assets
-37.9%
Return on Invested Capital
-483.0%
Current Ratio
2.48
Quick Ratio
2.34
Asset Turnover
0.44
Days Sales Outstanding
85.69
Days Payables Outstanding
—
Days Inventory On Hand
—
Cash Conversion Cycle
—
R&D / Revenue
111.4%
SBC / Revenue
—
Capex / Revenue
0.9%
Working Capital
$567M
Net Current Asset Value
$-654M
Invested Capital
$-80M
OCF / Net Income
0.81
FCF / Net Income
0.82
Accruals Ratio (Sloan)
-7.1%
Net Debt
$-421M
Net Debt / EBITDA
0.84
Capex Coverage
-77.67
Tangible Common Equity
$-300M
TCE / Total Assets
-19.6%
Goodwill / Total Assets
2.9%
NOPAT
$-423M
Cash ROIC
-539.4%
WC / Revenue
84.2%
Capex / D&A
0.17
Reinvestment Rate
5.4%
Asset Growth vs Revenue Growth
-18.2%
Revenue 5Y CAGR
19.9%
Book Value 5Y CAGR
-17.2%
Stock Price (FY-end)
$23
Market Cap
$2.27B
P/S Ratio
3.37
P/B Ratio
14.93
P/TB Ratio
115.37
Enterprise Value
$1.85B
EV / Sales
2.74
FCF Yield
-20.8%
R&D Yield
33.1%
Capex Yield
0.3%
Shares Variation (YoY)
9.0%
Beta (5Y)
1.11
Cost of Equity
10.0%
52W High
$46
52W Low
$20
Trailing Return 1Y
-47.0%
Trailing Return 5Y
-87.0%
F-Score (Piotroski)
4.00
Z-Score (Altman)
-3.56
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.